ArticleFuture medicinal chemistry2018

Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell lines.

Neetu Dayal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.